Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Nov 17, 10:02 AM10-Q cash drop and reverse-split proxy send GridAI down 24% after open
Index
-
Market Cap
35.41M
Enterprise Value
45.44M
Income
-22.72M
Sales
0.20M
Book/sh
2.80
Cash/sh
0.02
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
2
IPO
Oct 11, 2016
P/E
-
Forward P/E
-
PEG
-
P/S
177.05
P/B
1.23
P/C
147.54
P/FCF
-
EV/EBITDA
-
EV/Sales
227.20
Quick Ratio
0.26
Current Ratio
0.26
Debt/Eq
0.08
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-3.82
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
85.07% 88.24%
Sales past 3/5Y
- -
EPS Y/Y TTM
62.00%
Sales Y/Y TTM
-
EPS Q/Q
64.11%
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
149.35% -
Insider Own
18.25%
Insider Trans
0.00%
Inst Own
5.50%
Inst Trans
-
ROA
-25.01%
ROE
-42.08%
ROIC
-91.23%
Gross Margin
-1813.74%
Oper. Margin
-7544.25%
Profit Margin
-11450.21%
SMA20
-28.74%
SMA50
-19.48%
SMA200
-4.24%
Trades
Shs Outstand
10.27M
Shs Float
8.39M
52W High
6.93 -50.21%
52W Low
1.87 84.49%
Volatility
36.37% 18.08%
ATR (14)
0.73
RSI (14)
37.18
Beta
1.73
Rel Volume
0.00
Avg Volume
121.48K
Volume
0
Perf Week
-36.35%
Perf Month
-29.59%
Perf Quarter
-3.33%
Perf Half Y
-25.16%
Perf YTD
-25.97%
Perf Year
12.01%
Perf 3Y
-78.35%
Perf 5Y
-99.99%
Perf 10Y
-100.00%
Prev Close
3.45
Price
3.45
Change %
0.00%
GridAI Technologies Corp. is a diversified technology and life sciences company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.
Interim CEO & DirectorMr. Jason David Sawyer
Interim Chief Financial OfficerMs. Anna Skowron
Chief Executive Officer of GridAIMr. Marshall Chapin